Carcinoid tumors, also known as neuroendocrine tumors, are a type of cancer that can develop in certain types of cells throughout the body. The name “carcinoid” was coined in 1907 by the German pathologist Carl Sternberg and is derived from the Greek word “karkinos,” meaning crab. This type of tumor has become increasingly recognized in recent years, as advances in medical technology have made it easier to diagnose.
Neuroendocrine Tumors
Neuroendocrine tumors (NETs) are a type of carcinoid tumor that develops in the cells of the endocrine and nervous systems. NETs can occur anywhere in the body, but are most commonly found in the lung, digestive system, and pancreas. They can be either benign (non-cancerous) or malignant (cancerous).
NETs are typically slow-growing, meaning that they can remain undetected for a long time before symptoms appear. Symptoms can vary depending on the location of the tumor, but may include abdominal pain, nausea, vomiting, diarrhea, and changes in appetite or weight.
NETs are usually treated with surgery, chemotherapy, or targeted therapy, depending on the size and stage of the tumor. Treatment may also involve a combination of treatments, such as surgery and chemotherapy.
Neuroendocrine carcinoma is the new name for carcinoid tumors. This term is used to refer to malignant (cancerous) neuroendocrine tumors.